Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Radiopharmaceutical Therapy
1.2 Key Market Segments
1.2.1 Radiopharmaceutical Therapy Segment by Type
1.2.2 Radiopharmaceutical Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Radiopharmaceutical Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Radiopharmaceutical Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Radiopharmaceutical Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Radiopharmaceutical Therapy Market Competitive Landscape
3.1 Global Radiopharmaceutical Therapy Sales by Manufacturers (2019-2024)
3.2 Global Radiopharmaceutical Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Radiopharmaceutical Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Radiopharmaceutical Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Radiopharmaceutical Therapy Sales Sites, Area Served, Product Type
3.6 Radiopharmaceutical Therapy Market Competitive Situation and Trends
3.6.1 Radiopharmaceutical Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Radiopharmaceutical Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Radiopharmaceutical Therapy Industry Chain Analysis
4.1 Radiopharmaceutical Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Radiopharmaceutical Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Radiopharmaceutical Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiopharmaceutical Therapy Sales Market Share by Type (2019-2024)
6.3 Global Radiopharmaceutical Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Radiopharmaceutical Therapy Price by Type (2019-2024)
7 Radiopharmaceutical Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiopharmaceutical Therapy Market Sales by Application (2019-2024)
7.3 Global Radiopharmaceutical Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Radiopharmaceutical Therapy Sales Growth Rate by Application (2019-2024)
8 Radiopharmaceutical Therapy Market Segmentation by Region
8.1 Global Radiopharmaceutical Therapy Sales by Region
8.1.1 Global Radiopharmaceutical Therapy Sales by Region
8.1.2 Global Radiopharmaceutical Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Radiopharmaceutical Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Radiopharmaceutical Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Radiopharmaceutical Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Radiopharmaceutical Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Radiopharmaceutical Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bracco Imaging
9.1.1 Bracco Imaging Radiopharmaceutical Therapy Basic Information
9.1.2 Bracco Imaging Radiopharmaceutical Therapy Product Overview
9.1.3 Bracco Imaging Radiopharmaceutical Therapy Product Market Performance
9.1.4 Bracco Imaging Business Overview
9.1.5 Bracco Imaging Radiopharmaceutical Therapy SWOT Analysis
9.1.6 Bracco Imaging Recent Developments
9.2 Bayer
9.2.1 Bayer Radiopharmaceutical Therapy Basic Information
9.2.2 Bayer Radiopharmaceutical Therapy Product Overview
9.2.3 Bayer Radiopharmaceutical Therapy Product Market Performance
9.2.4 Bayer Business Overview
9.2.5 Bayer Radiopharmaceutical Therapy SWOT Analysis
9.2.6 Bayer Recent Developments
9.3 Mallinckrodt
9.3.1 Mallinckrodt Radiopharmaceutical Therapy Basic Information
9.3.2 Mallinckrodt Radiopharmaceutical Therapy Product Overview
9.3.3 Mallinckrodt Radiopharmaceutical Therapy Product Market Performance
9.3.4 Mallinckrodt Radiopharmaceutical Therapy SWOT Analysis
9.3.5 Mallinckrodt Business Overview
9.3.6 Mallinckrodt Recent Developments
9.4 Nordion
9.4.1 Nordion Radiopharmaceutical Therapy Basic Information
9.4.2 Nordion Radiopharmaceutical Therapy Product Overview
9.4.3 Nordion Radiopharmaceutical Therapy Product Market Performance
9.4.4 Nordion Business Overview
9.4.5 Nordion Recent Developments
9.5 Triad Isotopes
9.5.1 Triad Isotopes Radiopharmaceutical Therapy Basic Information
9.5.2 Triad Isotopes Radiopharmaceutical Therapy Product Overview
9.5.3 Triad Isotopes Radiopharmaceutical Therapy Product Market Performance
9.5.4 Triad Isotopes Business Overview
9.5.5 Triad Isotopes Recent Developments
9.6 Lantheus
9.6.1 Lantheus Radiopharmaceutical Therapy Basic Information
9.6.2 Lantheus Radiopharmaceutical Therapy Product Overview
9.6.3 Lantheus Radiopharmaceutical Therapy Product Market Performance
9.6.4 Lantheus Business Overview
9.6.5 Lantheus Recent Developments
9.7 IBA Group
9.7.1 IBA Group Radiopharmaceutical Therapy Basic Information
9.7.2 IBA Group Radiopharmaceutical Therapy Product Overview
9.7.3 IBA Group Radiopharmaceutical Therapy Product Market Performance
9.7.4 IBA Group Business Overview
9.7.5 IBA Group Recent Developments
9.8 GE Healthcare
9.8.1 GE Healthcare Radiopharmaceutical Therapy Basic Information
9.8.2 GE Healthcare Radiopharmaceutical Therapy Product Overview
9.8.3 GE Healthcare Radiopharmaceutical Therapy Product Market Performance
9.8.4 GE Healthcare Business Overview
9.8.5 GE Healthcare Recent Developments
9.9 China Isotope and Radiation
9.9.1 China Isotope and Radiation Radiopharmaceutical Therapy Basic Information
9.9.2 China Isotope and Radiation Radiopharmaceutical Therapy Product Overview
9.9.3 China Isotope and Radiation Radiopharmaceutical Therapy Product Market Performance
9.9.4 China Isotope and Radiation Business Overview
9.9.5 China Isotope and Radiation Recent Developments
9.10 Jubilant Pharma
9.10.1 Jubilant Pharma Radiopharmaceutical Therapy Basic Information
9.10.2 Jubilant Pharma Radiopharmaceutical Therapy Product Overview
9.10.3 Jubilant Pharma Radiopharmaceutical Therapy Product Market Performance
9.10.4 Jubilant Pharma Business Overview
9.10.5 Jubilant Pharma Recent Developments
9.11 Eli Lilly
9.11.1 Eli Lilly Radiopharmaceutical Therapy Basic Information
9.11.2 Eli Lilly Radiopharmaceutical Therapy Product Overview
9.11.3 Eli Lilly Radiopharmaceutical Therapy Product Market Performance
9.11.4 Eli Lilly Business Overview
9.11.5 Eli Lilly Recent Developments
9.12 Advanced Accelerator Applications
9.12.1 Advanced Accelerator Applications Radiopharmaceutical Therapy Basic Information
9.12.2 Advanced Accelerator Applications Radiopharmaceutical Therapy Product Overview
9.12.3 Advanced Accelerator Applications Radiopharmaceutical Therapy Product Market Performance
9.12.4 Advanced Accelerator Applications Business Overview
9.12.5 Advanced Accelerator Applications Recent Developments
9.13 SIEMENS
9.13.1 SIEMENS Radiopharmaceutical Therapy Basic Information
9.13.2 SIEMENS Radiopharmaceutical Therapy Product Overview
9.13.3 SIEMENS Radiopharmaceutical Therapy Product Market Performance
9.13.4 SIEMENS Business Overview
9.13.5 SIEMENS Recent Developments
9.14 Dongcheng
9.14.1 Dongcheng Radiopharmaceutical Therapy Basic Information
9.14.2 Dongcheng Radiopharmaceutical Therapy Product Overview
9.14.3 Dongcheng Radiopharmaceutical Therapy Product Market Performance
9.14.4 Dongcheng Business Overview
9.14.5 Dongcheng Recent Developments
9.15 Navidea
9.15.1 Navidea Radiopharmaceutical Therapy Basic Information
9.15.2 Navidea Radiopharmaceutical Therapy Product Overview
9.15.3 Navidea Radiopharmaceutical Therapy Product Market Performance
9.15.4 Navidea Business Overview
9.15.5 Navidea Recent Developments
10 Radiopharmaceutical Therapy Market Forecast by Region
10.1 Global Radiopharmaceutical Therapy Market Size Forecast
10.2 Global Radiopharmaceutical Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Radiopharmaceutical Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Radiopharmaceutical Therapy Market Size Forecast by Region
10.2.4 South America Radiopharmaceutical Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Radiopharmaceutical Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Radiopharmaceutical Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Radiopharmaceutical Therapy by Type (2025-2030)
11.1.2 Global Radiopharmaceutical Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Radiopharmaceutical Therapy by Type (2025-2030)
11.2 Global Radiopharmaceutical Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Radiopharmaceutical Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Radiopharmaceutical Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
